Advertisement

Introduction

  • Tricia A. Murdock
  • Emanuela F. T. Veras
  • Robert J. Kurman
  • Michael T. Mazur
Chapter

Abstract

Endometrial biopsies and curettings are among the most common tissue specimens received in the pathology laboratory. In several respects, these specimens present a unique challenge for the surgical pathologist. The normal endometrium undergoes a variety of morphologic changes, especially during the reproductive years, when cyclical hormonal influences and pregnancy affect uterine growth. Biopsy-induced artifacts confound this heterogeneous group of morphologic changes. Endometrial sampling techniques can vary from hysteroscopy with curettage, which is considered the “gold standard,” to a “blind” biopsy with no visualization of the tissue sampled. The final specimen contains multiple, irregularly oriented tissue fragments mixed with blood and contaminating cervical tissue and mucus.

Keywords

Endometrial biopsies Endometrial curettings Abnormal uterine bleeding Infertility Products of conception Hormonal therapy 

References

  1. 1.
    Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288:1610–21.CrossRefGoogle Scholar
  2. 2.
    Visser NCM, Reijnen C, Massuger LFAG, Nagtegaal ID, Bulten J, Pijnenborg JMA. Accuracy of endometrial sampling in endometrial carcinoma: a systematic review and meta-analysis. Obstet Gynecol. 2017;130:803–13.CrossRefGoogle Scholar
  3. 3.
    Gkrozou F, Dimakopoulos G, Vrekoussis T, Lavasidis L, Koutlas A, Navrozoglou I, Stefos T, Paschopoulos M. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet. 2015;291:1347–54.CrossRefGoogle Scholar
  4. 4.
    Svirsky R, Smorgick N, Rozowski U, Sagiv R, Feingold M, Halperin R, Pansky M. Can we rely on blind endometrial biopsy for detection of focal intrauterine pathology? Am J Obstet Gynecol. 2008;199:115.e1–3.CrossRefGoogle Scholar
  5. 5.
    Baitlon D, Hadley JO. Endometrial biopsy. Pathologic findings in 3,600 biopsies from selected patients. Am J Clin Pathol. 1975;63:9–15.CrossRefGoogle Scholar
  6. 6.
    Nickelsen C. Diagnostic and curative value of uterine curettage. Acta Obstet Gynecol Scand. 1986;65:693–7.Google Scholar
  7. 7.
    Van Bogaert LJ, Maldague P, Staquet JP. Endometrial biopsy interpretation. Shortcomings and problems in current gynecologic practice. Obstet Gynecol. 1978;51:25–8.PubMedGoogle Scholar
  8. 8.
    Galle PC, McRae MA. Abnormal uterine bleeding. Finding and treating the cause. Postgrad Med. 1993;93:73–6. 80–81CrossRefGoogle Scholar
  9. 9.
    Merrill JA. The interpretation of endometrial biopsies. Clin Obstet Gynecol. 1991;34:211–21.CrossRefGoogle Scholar
  10. 10.
    Goldstein RB, Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, Fleischer AC, Goldstein SR, Hunt RB, Kurman RJ, Kurtz AB, Laing FC, Parsons AK, Smith-Bindman R, Walker J. Evaluation of the woman with postmenopausal bleeding: society of Radiologists in ultrasound-sponsored consensus conference statement. J Ultrasound Med. 2001;20:1025–36.CrossRefGoogle Scholar
  11. 11.
    Patel V, Wilkinson EJ, Chamala S, Lu X, Castagno J, Rush D. Endometrial thickness as measured by transvaginal ultrasound and the corresponding histopathologic diagnosis in women with postmenopausal bleeding. Int J Gynecol Pathol. 2017;36:348–55.CrossRefGoogle Scholar
  12. 12.
    Fleischer A, Abramowicz J, Goncalves L, Manning F, Monteagudo A, Timor I, Toy E, editors. Sonographic techniques for early detection of ovarian and endometrial cancers. Fleischer’s sonography in obstetrics and gynecology. 8th ed. New York: McGraw Hill Education; 2018.Google Scholar
  13. 13.
    Stovall TG, Solomon SK, Ling FW. Endometrial sampling prior to hysterectomy. Obstet Gynecol. 1989;73:405–9.PubMedGoogle Scholar
  14. 14.
    Ramm O, Gleason JL, Segal S, Antosh DD, Kenton KS. Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction. Int Urogynecol J. 2012;23:913–7.CrossRefGoogle Scholar
  15. 15.
    Archer DF, McIntyre-Seltman K, Wilborn WW, Dowling EA, Cone F, Creasy GW, Kafrissen ME. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol. 1991;165:317–20. discussion 320–322.CrossRefGoogle Scholar
  16. 16.
    Louie M, Canavan TP, Mansuria S. Threshold for endometrial sampling among postmenopausal patients without vaginal bleeding. Int J Gynaecol Obstet. 2016;132:314–7.CrossRefGoogle Scholar
  17. 17.
    McPencow AM, Erekson EA, Guess MK, Martin DK, Patel DA, Xu X. Cost-effectiveness of endometrial evaluation prior to morcellation in surgical procedures for prolapse. Am J Obstet Gynecol. 2013;209:22.e1–9.CrossRefGoogle Scholar
  18. 18.
    Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO working group on menstrual disorders: FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3–13.CrossRefGoogle Scholar
  19. 19.
    Goldfarb JM, Little AB. Current concepts: abnormal vaginal bleeding. N Engl J Med. 1980;302:666–9.CrossRefGoogle Scholar
  20. 20.
    Povey WG. Abnormal uterine bleeding at puberty and climacteric. Clin Obstet Gynecol. 1970;13:474–88.CrossRefGoogle Scholar
  21. 21.
    Kilbourn CL, Richards CS. Abnormal uterine bleeding. Diagnostic considerations, management options. Postgrad Med 2001;109:137–138, 141–144, 147–150.CrossRefGoogle Scholar
  22. 22.
    Wren BG. Dysfunctional uterine bleeding. Aust Fam Physician. 1998;27:371–7.PubMedGoogle Scholar
  23. 23.
    Fraser IS, Critchley HOD, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29:383–90.CrossRefGoogle Scholar
  24. 24.
    Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: LWW; 2010.Google Scholar
  25. 25.
    Rubin SC. Postmenopausal bleeding: etiology, evaluation, and management. Med Clin North Am. 1987;71:59–69.CrossRefGoogle Scholar
  26. 26.
    Schindler AE, Schmidt G. Post-menopausal bleeding: a study of more than 1000 cases. Maturitas. 1980;2:269–74.CrossRefGoogle Scholar
  27. 27.
    Van Bogaert LJ. Clinicopathologic findings in endometrial polyps. Obstet Gynecol. 1988;71:771–3.PubMedGoogle Scholar
  28. 28.
    Choo YC, Mak KC, Hsu C, Wong TS, Ma HK. Postmenopausal uterine bleeding of nonorganic cause. Obstet Gynecol. 1985;66:225–8.PubMedGoogle Scholar
  29. 29.
    Mencaglia L, Perino A, Hamou J. Hysteroscopy in perimenopausal and postmenopausal women with abnormal uterine bleeding. J Reprod Med. 1987;32:577–82.PubMedGoogle Scholar
  30. 30.
    Pacheco JC, Kempers RD. Etiology of postmenopausal bleeding. Obstet Gynecol. 1968;32:40–6.PubMedGoogle Scholar
  31. 31.
    Lidor A, Ismajovich B, Confino E, David MP. Histopathological findings in 226 women with post-menopausal uterine bleeding. Acta Obstet Gynecol Scand. 1986;65:41–3.CrossRefGoogle Scholar
  32. 32.
    Moghal N. Diagnostic value of endometrial curettage in abnormal uterine bleeding – a histopathological study. J Pak Med Assoc. 1997;47:295–9.PubMedGoogle Scholar
  33. 33.
    Van den Bosch T, Ameye L, Van Schoubroeck D, Bourne T, Timmerman D. Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Facts Views Vis Obgyn. 2015;7:17–24.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Ricciardi E, Vecchione A, Marci R, Schimberni M, Frega A, Maniglio P, Caserta D, Moscarini M. Clinical factors and malignancy in endometrial polyps. Analysis of 1027 cases. Eur J Obstet Gynecol Reprod Biol. 2014;183:121–4.CrossRefGoogle Scholar
  35. 35.
    Meyer WC, Malkasian GD, Dockerty MB, Decker DG. Postmenopausal bleeding from atrophic endometrium. Obstet Gynecol. 1971;38:731–8.PubMedGoogle Scholar
  36. 36.
    Gambrell RD. Postmenopausal bleeding. J Am Geriatr Soc. 1974;22:337–43.CrossRefGoogle Scholar
  37. 37.
    Wise MR, Gill P, Lensen S, Thompson JMD, Farquhar CM. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am J Obstet Gynecol. 2016;215:598.e1–8.CrossRefGoogle Scholar
  38. 38.
    Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB. Calculation of risk of colorectal and endometrial cancer among patients with lynch syndrome. Gastroenterology. 2009;137:1621–7.CrossRefGoogle Scholar
  39. 39.
    Pennington KP, Walsh T, Lee M, Pennil C, Novetsky AP, Agnew KJ, Thornton A, Garcia R, Mutch D, King M-C, Goodfellow P, Swisher EM. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer. 2013;119:332–8.CrossRefGoogle Scholar
  40. 40.
    Tan M-H, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18:400–7.CrossRefGoogle Scholar
  41. 41.
    van Lier MGF, Wagner A, Mathus-Vliegen EMH, Kuipers EJ, Steyerberg EW, van Leerdam ME. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 2010;105:1258–64. author reply 1265.CrossRefGoogle Scholar
  42. 42.
    Ring KL, Garcia C, Thomas MH, Modesitt SC. Current and future role of genetic screening in gynecologic malignancies. Am J Obstet Gynecol. 2017;217:512–21.CrossRefGoogle Scholar
  43. 43.
    Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995;346:995–1000.CrossRefGoogle Scholar
  44. 44.
    Harris HR, Terry KL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract. 2016;2:14.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Tricia A. Murdock
    • 1
  • Emanuela F. T. Veras
    • 1
  • Robert J. Kurman
    • 1
  • Michael T. Mazur
    • 2
  1. 1.Department of PathologyThe Johns Hopkins HospitalBaltimoreUSA
  2. 2.Department of Pathology and Laboratory MedicineState University of New York Upstate Medical UniversitySyracuseUSA

Personalised recommendations